News Archive

Showing 18 results

March 2023

Media ReleaseMar 06, 2023
Novartis, Telstra Health and Monash University join forces to tackle Australia’s number one killer – heart disease
A new partnership combining innovative medicines, digital healthcare, and clinical care for heart health, will see trial of new model of care for Aussies at risk of cardiovascular disease (CVD).…

September 2022

Media ReleaseSep 29, 2022
Industry and clinical collaboration delivers screening pilot for heart wellness – yet more awareness and access needed to address Australia’s biggest killer
One Australian dies of cardiovascular disease (CVD) every 12 minutes.1,2 More proactive heart screening could help close a gap in our nation’s health system. Australians encouraged to get a heart…

May 2022

Media ReleaseMay 01, 2022
Australia’s first gene therapy for babies born with spinal muscular atrophy (SMA), Zolgensma®, becomes available on the PBS
Zolgensma® becomes the first gene therapy in Australia for children under the age of 9 months with spinal muscular atrophy (SMA) to be listed on the Pharmaceutical Benefits Scheme (PBS)1 1 in 10,…

June 2021

Media ReleaseJun 01, 2021
Novartis Australia becomes a certified “Family Friendly” workplace
Novartis has welcomed the opportunity to be part the new Family Friendly Workplaces accreditation initiative, which not only assesses how it’s doing, but also lays out a plan for raising the bar in…

May 2021

Media ReleaseMay 24, 2021
International Clinical Trials Day
COVID-safe measures such as telehealth consults for trials, and local deliveries of trial medicines are now serving to improve clinical trial processes beyond the pandemic Australia’s contribution…

October 2020

Media ReleaseOct 01, 2020
Novartis launches a ‘Wellness Day’ scheme – Encouraging employees to check-in on their health and set new community behaviours
All Novartis employees encouraged to take a day off work to schedule potentially life-saving health-screen check For every health screening completed – Novartis will donate $5 to both local cancer…

September 2020

Media ReleaseSep 02, 2020
Novartis Australia redefines flexible work policies in response to pandemic challenges
With COVID-19 restrictions significantly impacting on traditional ways of working, Novartis Australia is offering associates the choice to decide how, where and when they work. Novartis’ new…

May 2020

Featured NewsMay 28, 2020
Novartis Australia responds to pandemic challenges faced by patient organisations

April 2020

Media ReleaseApr 02, 2020
Novartis to assist Australian Government with initial supply of hydroxychloroquine
Novartis Australia, and its generics and biosimilars division Sandoz, has confirmed that it will be working with the Australian government to provide an initial supply of generic hydroxychloroquine…

March 2020

January 2020

Media ReleaseJan 10, 2020
The Australian Bushfires
The Novartis community would like to express our thoughts and condolences to all of those affected by the bushfires in Australia. While the disaster is not yet over, we thank all of the firefighters…